Literature DB >> 18497226

Healthcare professionals' views of screening for postnatal depression.

Linda Mason1, Helen Poole.   

Abstract

Despite the widespread use of screening for postnatal depression using the Edinburgh Postnatal Depression Scale (EPDS) in England, little is known about the views of those healthcare professionals (HPs) who administer it. The current study aimed to address this, using a qualitative methodology to access the perceptions of HPs toward screening using this tool. A total of 19 semi-structured interviews were conducted in one primary care Trust (PCT). The results were analysed in the context of recommendations made by Unite/CPHVA and the National Screening Committee (NSC). Although training was provided in the PCT, some HPs had screened before being trained. All participants felt that the EPDS was useful, but for some this was only as a way to introduce the subject of postnatal depression. While some thought the tool was good generally, others reported problems with it, particularly in relation to item 10 on self harm. We found large differences in screening practice related to timing, environment and repeat screenings. We have made suggestions to alter practice so that it both meets recommendations made by Unite/CPHVA and the NSC, and ensures women receive the same standard of care across the PCT.

Entities:  

Mesh:

Year:  2008        PMID: 18497226

Source DB:  PubMed          Journal:  Community Pract        ISSN: 1462-2815


  2 in total

Review 1.  Perceived benefits and limitations of using patient-reported outcome measures in clinical practice with individual patients: a systematic review of qualitative studies.

Authors:  Rachel Campbell; Angela Ju; Madeleine T King; Claudia Rutherford
Journal:  Qual Life Res       Date:  2021-09-27       Impact factor: 4.147

2.  Health care professionals' experiences of screening immigrant mothers for postpartum depression-a qualitative systematic review.

Authors:  Malin Skoog; Inger Kristensson Hallström; Andreas Vilhelmsson
Journal:  PLoS One       Date:  2022-07-14       Impact factor: 3.752

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.